scispace - formally typeset
W

Weiping Zhu

Researcher at East China University of Science and Technology

Publications -  127
Citations -  3959

Weiping Zhu is an academic researcher from East China University of Science and Technology. The author has contributed to research in topics: Fluorescence & Aqueous solution. The author has an hindex of 31, co-authored 116 publications receiving 3438 citations.

Papers
More filters
Journal ArticleDOI

A Highly Sensitive and Selective OFF-ON Fluorescent Sensor for Cadmium in Aqueous Solution and Living Cell

TL;DR: A highly selective and sensitive OFF-ON fluorescent sensor 1, employing the PET mechanism, was designed and synthesized and could be used to detect Cd(2+) ion in aqueous solution and to image Cd (2+) ion in living cells.
Journal ArticleDOI

FRET-Based Mito-Specific Fluorescent Probe for Ratiometric Detection and Imaging of Endogenous Peroxynitrite: Dyad of Cy3 and Cy5.

TL;DR: A FRET-based small-molecule fluorescent probe (PNCy3Cy5) is developed, harnessing the differential reactivity of Cy3 and Cy5 toward OONO(-) by fine-tuning and exhibits high detection sensitivity and yields a ratiometric fluorescent signal.
Journal ArticleDOI

A highly selective fluorescent probe for fast detection of hydrogen sulfide in aqueous solution and living cells

TL;DR: A new ratiometric fluorescence probe E1 based on an excited-state intramolecular proton transfer (ESIPT) mechanism for detection of hydrogen sulfide (H(2)S) is reported and showed a 30-fold fluorescence enhancement in 2 minutes.
Journal ArticleDOI

A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell.

TL;DR: Based on the hypoxia prodrug moiety of p-nitrobenzyl, a selective ratiometric fluorescent sensor (RHP) was designed and synthesized and results in an evident blue to green fluorescent emission wavelength change in both solution phases and in cell lines, which might be the first fluorescentRatiometric probe for Hypoxia in solid tumors.
Journal ArticleDOI

A New Class of Naphthalimide-Based Antitumor Agents That Inhibit Topoisomerase II and Induce Lysosomal Membrane Permeabilization and Apoptosis

TL;DR: A new paradigm was suggested for the design of novel multitarget anticancer drugs after a new class of naphthalimides was designed, synthesized, and proved to inhibit topoisomerase II, induced lysosomal membrane permeabilization, and ultimately caused apoptosis and cell death.